BACKGROUND Cardiac toxicity is the foremost reason for drug discontinuation from development to clinical evaluation and post market surveillance [Fung 35:293-317, 2001; Piccini 158:317-326 2009]. The Food and Drug Administration (FDA) has rejected many potential pharmaceutical agents due to QT prolongation effects. Since drug development and FDA approval takes an enormous amount of time, money ...

This paper investigates the aspects of dispersion nanoparticles in blood capillaries linked to nanodrug delivery systems. Nanoparticles are injected intravenously and resultant fluid has been identified as nanofluid. The viscosity nanofluid is modelled using nanoparticle size dependent relation. properties studied power law fluid, owing their physically close simulations. model framed here solv...

In recent years, Prussian blue nanoparticles (PB-NPs) and theire analogues, that exhibit an increased catalytic activity, have attracted considerable attention in nanotechnology. Such are regarded as alternative to natural enzymes intensively used biosensorics, diagnostics experimental biomedicine. Recently, it has been shown their analogs, also referred “nanozymes”, can be active oxygen scaven...